Cisplatin binding sites on human albumin

Ivanov, Andrei I. and Christodoulou, John and Parkinson, John A. and Barnham, Kevin J. and Tucker, Alan and Woodrow, John and Sadler, Peter J. (1998) Cisplatin binding sites on human albumin. Journal of Biological Chemistry, 273 (24). pp. 14721-14730. ISSN 1083-351X (https://doi.org/10.1074/jbc.273.24.14721)

[thumbnail of Ivanov-etal-JBC-1998-Cisplatin-binding-sites-on-human]
Preview
 Text. Filename: Ivanov-etal-JBC-1998-Cisplatin-binding-sites-on-human.pdf
Final Published Version
License: Creative Commons Attribution 4.0 logo
Download (489kB)| Preview

Abstract

Reactions of cisplatin (cis -[PtCl2(NH3)2]) with albumin are thought to play an important role in the metabolism of this anticancer drug. They are investigated here via (i) labeling of cisplatin with 15N and use of two-dimensional 1H,15N NMR spectroscopy, (ii) comparison of natural human serum albumin with recombinant human albumin (higher homogeneity and SH content), (iii) chemical modification of Cys, Met, and His residues, (iv) reactions of bound platinum with thiourea, and (v) gel filtration chromatography. In contrast to previous reports, it is shown that the major sulfur-containing binding site involves Met and not Cys-34, and also a N ligand, in the form of an S,N macrochelate. Additional monofunctional adducts involving other Met residues and Cys-34 are also observed. During the later stages of reactions of cisplatin with albumin, release of NH3 occurs due to the strong trans influence of Met sulfur, which weakens the Pt-NH3 bonds, and protein cross-linking is observed. The consequences of these findings for the biological activity of cisplatin-albumin complexes are discussed.

ORCID iDs

Ivanov, Andrei I., Christodoulou, John, Parkinson, John A. ORCID logoORCID: https://orcid.org/0000-0003-4270-6135, Barnham, Kevin J., Tucker, Alan, Woodrow, John and Sadler, Peter J.;
CORE (COnnecting REpositories)